echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > my country's independent research and development of a variety of effective drugs for the new coronavirus has been used in clinical treatment

    my country's independent research and development of a variety of effective drugs for the new coronavirus has been used in clinical treatment

    • Last Update: 2021-12-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
    While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
    .
     
    After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
    .
    According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
    .
     
    During the development of new coronavirus drugs, China has deployed three technical routes
    .
    At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
    .
     
    Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
    A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
    .
      The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
    While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
    .
     
      After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
    .
    According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
    .
     
      During the development of new coronavirus drugs, China has deployed three technical routes
    .
    At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
    .
     
      Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
    A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
    .
      The number of mutations of the new coronavirus has increased, and the variant strains are prevalent in many countries.
    While the new coronavirus vaccine has achieved effective prevention and control, where is my country's research and development of effective drugs for the new coronavirus? What are the candidate "seed medicines"? Let's take a look at the development process of China's new crown drugs
    .
     
      After the outbreak of the new crown pneumonia, China immediately deployed drug research and development tasks, organized a national team of experts, and focused on clinical treatment needs to fully promote the research and development of effective drugs and treatment technologies
    .
    According to the relevant person in charge, 53 scientific research emergency projects in the clinical treatment and drug sector have been approved, involving about 315 million yuan of state-appropriated funds
    .
     
      During the development of new coronavirus drugs, China has deployed three technical routes
    .
    At present, the research and development of effective drugs for the new coronavirus is mainly carried out around three technical routes: blocking the virus from entering cells, inhibiting virus replication, and regulating the human immune system
    .
     
      Up to now, China has formed a combination therapy of BRII-196 and BRII-198 neutralizing antibodies that block virus entry into cells, procrudide, azvudine that inhibits virus replication, and a monoclonal antibody BDB-001 that modulates the human immune system.
    A batch of key drugs such as injections, and a variety of effective drugs for the new coronavirus independently developed by our R&D team have been used in clinical treatment
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.